The FTA-ABS test is a blood test to detect antibodies to the bacteria Treponema pallidum, which causes syphilis.
This test is used when a screening test for syphilis is positive to confirm that there is a true infection.
How is the Test Performed?
A blood sample is needed. For information on how this is done, see: Venipuncture
Preparation for the Test
No special preparation is necessary.
How the Test will Feel
When the needle is inserted to draw blood, you may feel moderate pain, or only a prick or stinging sensation. Afterward, there may be some throbbing.
Why is the Test Performed?
It may also be done when other syphilis tests are negative, to rule out a possible false-negative result.
Normal Results for FTA-ABS test
A negative or nonreactive result means there you do not have a current or past infection with syphilis.
Normal value ranges may vary slightly among different laboratories. Some labs use different measurements or test different samples. Talk to your doctor about the meaning of your specific test results.
What Abnormal Results Mean
A positive FTA-ABS is usually a sign of a syphilis infection. This test result will remain positive for life even if syphilis has been adequately treated. Therefore, it cannot be used to monitor the treatment of syphilis or determine that you have active syphilis.
Other illnesses such as yaws and pinta may also result in positive FTA-ABS results. Occasionally there can be a false positive result, most often in women with lupus.
FTA-ABS test Risks
Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
Other risks associated with having blood drawn are slight but may include:
- Excessive bleeding
- Fainting or feeling light-headed
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
Tramont EC. Treponema pallidum (syphilis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2009:chap 238.
|Review Date: 9/1/2013
Reviewed By: Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Bethanne Black, and the A.D.A.M. Editorial team.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
© Copyright 1997- 2018 A.D.A.M., Inc.